Related by context. All words. (Click for frequent words.) 71 copromotion 71 commercializing Loramyc ® 68 Tibotec BVBA 68 Kosan dependence 68 JV SpeBio 67 Boehringer Ingelheim MedImmune 67 Fovea Pharmaceuticals 67 Initiates Phase III 67 Roche SWX ROG 67 SpeBio joint venture 66 Gentamicin Surgical Implant 66 Taiho Pharmaceutical 66 Initiates Enrollment 66 Receives Milestone Payment 66 Kiadis 65 Boehringer Ingelheim CHDI Novartis 65 carbonate Direct FuelCell 65 Nycomed GmbH 65 Galderma SA 65 Germany FSE SCH 65 Pharma Merck Serono 65 BioSante Pharmaceuticals Announces 65 Sankyo Pharma 64 Initiates Clinical Trial 64 Syntonix Pharmaceuticals 64 Initiates Phase II 64 methylnaltrexone bromide 64 Medtronic Novartis 64 Roche Trimeris 64 Quark Biotech 64 Idec Roche Takeda 64 Biogen Idec Roche 64 IG HCR ;) CO 64 Idec Roche 64 Merck OSI Pharmaceuticals 64 Submits IND 64 Receives Orphan Drug Designation 63 SOLVAY PHARMACEUTICALS 63 Submits Response 63 Paris IPN Euronext 63 NASDAQ CRXL 63 Fresenius Biotech 63 Announces Tentative Approval 63 Prism Pharmaceuticals 63 Teikoku Seiyaku Co. 63 Submits Biologics License Application 63 outlicensed 63 Files IND 63 Exploit collaboration 63 Graffinity Pharmaceuticals 63 BioGeneriX AG 63 Lilly ICOS LLC 63 Takeda Kyowa Hakko Kirin 63 Therapeutic Competitors Companies 63 miconazole MBT 63 IPSEN 63 SANOFI AVENTIS 63 Les Laboratoires Servier 63 Organon Pharmaceuticals 63 Initiates Clinical 63 Astex Therapeutics 63 AstraZeneca MedImmune 63 Inc. www.micromet inc.com 63 HuCAL PLATINUM R 63 Treximet ® 63 Alza Corporation 62 co licensor KDL 62 CancerVax Corporation 62 CysDisplay R 62 Dynepo TM 62 Receives Approvable Letter 62 BioGlue ® 62 Asentar TM 62 Crucell NV NYSE Euronext 62 GTC NASDAQ GTCB 62 Namenda Memantine HCl 62 Kuvan R 62 Squibb Eli Lilly 62 Announce License Agreement 62 MEDAREX 62 Oral Suspension USP 62 Receives CE Marking 62 Akorn Strides 62 Cephalon GlaxoSmithKline 62 Receives Tentative Approval 62 Crofelemer budesonide foam 62 RECOTHROM ® 62 Crucell NV Euronext 62 gets USFDA nod 62 Sensipar ® 62 Takeda Kyowa Hakko 62 SPL# Gel vaginal microbicide 62 Gruppo Angelini 62 Genentech Wyeth Pharmaceuticals 62 STO SOBI 62 Alaven 62 Completes Patient Enrollment 62 XP# XP# 62 Grunenthal GmbH 62 Endotis 62 Biovitrum AB 62 Therapeutic Competitors Report 62 cathepsin K inhibitor 61 Locteron exclusively 61 RELISTOR ® 61 Announce Licensing 61 AnGes MG Inc. 61 Initiates Phase 2b 61 Nasdaq CRXL 61 Cadila Pharmaceuticals named 61 HepeX B 61 ENZON 61 Initiates Dosing 61 Primus Pharmaceuticals 61 Enters Into Collaboration 61 Terminate Merger Agreement 61 Teikoku Pharma USA 61 Ercole Biotech 61 Develop Novel 61 GlaxoSmithKline MedImmune 61 Creabilis Therapeutics 61 CIMZIA r 61 TKPHF 61 Submits NDA 61 Roche SIX RO 61 Tyzeka Sebivo 61 Veronate R 61 acetonide FA 61 UCB Pharma SA 61 Neuro3d 61 PDE# inhibitors 61 Cutanea Life Sciences 61 Sanochemia Pharmazeutika AG 61 BioFocus DPI Galapagos 61 Granted Orphan Drug 61 Phenomix Corporation 61 Naglazyme R 61 Taisho Pharmaceuticals 61 OMRIX Biopharmaceuticals 61 Gendux AB 61 Ingenium Pharmaceuticals AG 61 Nasdaq CGEN 61 Cenix BioScience 61 RTP #i 61 Meets Primary Endpoint 61 BRILINTA 61 Sign Definitive Merger 61 GTC recombinant form 61 ESBATech AG 61 Rheoscience 61 Initiates Clinical Trials 61 Idera Pharmaceuticals 61 Vernalis plc 61 mGluR2 positive 61 PAION AG 61 EpiTherapeutics 61 Licenses Novel 61 label Lipofen R 61 Announces License Agreement 61 vapreotide acetate 60 Begins Dosing 60 Rosetta dependence 60 JAK2 Inhibitor 60 Agonist MABA program 60 Captisol ® 60 Zeneus 60 HuCAL GOLD R 60 novel emulsion formulation 60 BioGlue R 60 Oral Calcitonin 60 ARCALYST R 60 vinorelbine emulsion 60 Vitrasert R 60 Preotact R 60 Fujisawa Healthcare Inc. 60 OSI Eyetech 60 Xcytrin R 60 Aganocide TM 60 Qutenza TM 60 Inks License 60 InvaGen 60 DP VPA 60 Alligator Bioscience AB 60 SinuNase ™ 60 GlycArt 60 Enrolls First 60 Fumapharm AG 60 Advancis Pharmaceutical Corporation 60 Norgine BV 60 Merck Serono division 60 Tibotec Pharmaceuticals Ltd. 60 International LAB Pharma 60 Cenomed 60 Sumitomo Pharmaceuticals 60 candidates Azedra TM 60 Targeted Chemotherapy 60 TM Aganocide 60 Fibrosis Foundation Therapeutics 60 delivery polymer matrix 60 Diatos SA 60 AB OMXS BINV 60 Evolva 60 Glaxo Wellcome plc 60 MOVIPREP R 60 AcryMed Incorporated 60 Janssen Pharmaceutica NV 60 successfully commercialize Iluvien 60 Gedeon Richter Plc 60 euro adhoc Intercell AG 60 Enzo Therapeutics 60 Xeloda ® 60 CIMA LABS 60 Somatuline R Autogel R 60 Fortigel 60 Increlex TM 60 pharmacogenomic translational research 60 MorphoSys Galapagos 60 ZALBIN ™ 60 Somaxon interpretation 60 Transcept Pharmaceuticals 60 Merck MedImmune ChemDiv 60 Raven Biotechnologies 60 dutogliptin 60 Cellegesic 60 ABILIFY R 60 elbion 60 dextromethorphan quinidine 60 TELINTRA R 60 commercialize omacetaxine 60 Multiple Ascending Dose 60 VYVANSE TM lisdexamfetamine 60 Handok Pharmaceuticals 60 Vascular Wrap TM 60 Adenuric R 60 compound KOS 60 BioGeneriX 60 Myc pathways 60 Japanese drugmaker Daiichi 60 Roche OTC RHHBY 60 Files Investigational 60 development DSC# novel 60 5 lipoxygenase activating 60 Announce Collaboration Agreement 60 PRN FDA Approves 60 ICOS Corporation 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 Aradigm Logo 60 Specialised Therapeutics Australia 59 Presents Preclinical Data 59 TRANSDUR ™ 59 Andromeda Teva 59 Glaxo Wellcome PLC 59 sanofi aventis Bayer Schering 59 R MSCRAMM 59 Novartis NVS Snapshot Report 59 Receives Orphan Drug 59 NYSE SHR 59 SBL Vaccines 59 License Option Agreement 59 gastrointestinal disorders ATI 59 Nippon Shinyaku 59 Lantibio 59 ELADUR ™ 59 Presents Positive 59 Merz Pharma GmbH 59 www.ucb group.com 59 Merck Serono Nycomed 59 REG1 Anticoagulation System 59 Merck Sante sas 59 Max Neeman International 59 Glenmark Pharmaceuticals SA 59 Teveten 59 TransPharma 59 Copegus R 59 Aldara ® 59 Loramyc ™ 59 diabetes irritable bowel 59 Quinapril 59 Ferring Pharmaceuticals privately 59 Receives Fast Track 59 Alnylam Nasdaq ALNY 59 personalized dendritic 59 Presents Preclinical 59 Sigma Tau Pharmaceuticals 59 Bertek Pharmaceuticals 59 targeted anticancer therapies 59 & LSE GLPG 59 Adenoscan R 59 RAPTIVA R 59 synthetic ligand affinity 59 rThrombin 59 Lovaza TM 59 SCHWARZ PHARMA 59 Milestone Payment 59 Auxilium Pharma 59 product platforms AZX# 59 Reports Preclinical Data 59 Vifor Pharma 59 Janssen AI 59 Launches Generic Version 59 OTCBB HXBM developer 59 Nitec Pharma 59 includes Dideco CarboMedics 59 Rapinyl 59 Neulasta R 59 Agensys subsidiary 59 Obtains License 59 Timolol ophthalmic solution 59 epoetin zeta 59 Arno Therapeutics 59 ViroChem Pharma Inc. 59 ALZA Corporation 59 DARA logo 59 Zor Pharmaceuticals 59 Receive Milestone Payment 59 TRANSDUR ® 59 Successfully Completes Phase 59 EHT AGN 59 Potelligent Technology 59 Ecallantide 59 Forges Strategic 59 CIMAB SA 59 Menarini Group 59 Femring ® 59 DeveloGen 59 RAPTIVA r 59 Onco Therapies 59 miconazole Lauriad ® 59 Campto 59 Alnylam Pharma 59 TRACON Pharmaceuticals 59 proprietary radiolabeled monoclonal 59 SYCREST 59 OTCBB PYTO 59 markets HP Acthar 59 commercialize AzaSite 59 ELADUR TM 59 sanofi aventis EURONEXT SAN 59 COLAZAL R 59 OMAPRO ™ 59 Zygogen 59 Altana Pharma AG 59 oral salmon calcitonin 59 Eraxis 59 Orapred ODT 59 Agennix Incorporated 59 elbion GmbH 59 Inc. NASDAQ NOVC 59 TransPharma Medical Ltd. 59 Novartis Organon 59 HCV RNA polymerase 59 BAYRY 59 Novacort 59 Nitec 59 INSPIRE Trial Phase III 59 Establish Strategic 59 oral dihydropyrimidine dehydrogenase DPD 59 Risperidone Oral Solution 59 XIAFLEX ® 59 Seikagaku Corporation 59 KAI Pharmaceuticals 59 Zenvia ™ 59 Other ImmunoGen collaborative 59 Alnylam Pharmaceuticals Nasdaq ALNY 59 Thrombin topical Recombinant 59 Omigard TM 59 pralatrexate injection folate analogue 59 OTCBB NVDL 59 Gruenenthal 59 novel MetAP 2 59 outlicensing 59 SIRO Clinpharm 59 Amends Agreement 59 Mylan Receives Approval 59 Proquin XR 58 PF # [002] 58 MKC# MKC# PP 58 OSI commercializes Macugen 58 developing ACAPODENE 58 Dyax logo 58 Kissei Pharmaceutical 58 wholly owned immunotherapeutics 58 Prometheus Laboratories 58 Presents Positive Preclinical 58 Extends Collaboration 58 non nucleoside inhibitor 58 BioDelivery Sciences Announces 58 Immunotherapeutic 58 * olmesartan medoxomil 58 Cerenis Therapeutics 58 STEDESA 58 AMEX ISV 58 Portola Pharmaceuticals 58 Akzo Organon 58 Archemix Corp. 58 Earns Milestone Payment 58 Debiopharm SA 58 Beerse Belgium 58 eprodisate KIACTA TM 58 hyaluronidase enzyme 58 www.ucb.com 58 Pegloticase 58 cosmetic cosmeceutical products 58 acne impetigo 58 Oasmia 58 Pepscan Therapeutics 58 Ondansetron Injection 58 Enters Strategic 58 Oxytrol R 58 Lexiscan R 58 Successfully Completes Tender Offer 58 Fabre Kramer 58 Modrenal R 58 PentaLyte R 58 Curacyte 58 Crucell PER.C6 58 Cardioxyl Pharmaceuticals 58 commercialize Aganocides 58 Melior Discovery 58 Completes Enrollment 58 Bayer Yakuhin 58 Somatuline Depot 58 Intravenous Human 58 NovaThera 58 JCR Pharmaceuticals 58 acyclovir Lauriad R 58 Cerexa Inc. 58 Spiegelmer ® 58 HELSINN 58 Medtronic Novartis Biogen 58 NASDAQ CGEN announced 58 Sign Licensing Agreement 58 adenosine A2A 58 CombinatoRx Incorporated 58 Immunex Corporation 58 Kuvan TM sapropterin 58 Announce Merger Agreement 58 intravenous AAT 58 Gastrotech 58 Axcan Pharma Holding BV 58 Announces Definitive Merger 58 lead compound Traficet 58 Polyphenon ® E 58 Fumapharm 58 NUEDEXTA ™ 58 AkaRx 58 commercialize telaprevir 58 microRNA Therapeutics 58 prokinetic agent 58 ZBx 58 glucokinase activator 58 HuMax TAC 58 developing Zerenex ferric 58 Regeneron Pharma 58 Jaiva Technologies 58 Gets FDA Clearance 58 Genotyping Test 58 Atripla combines 58 Onalta 58 Kirin Pharma 58 Methylphenidate Transdermal System 58 OncoGenex Technologies 58 Lupin Pharmaceuticals 58 commercialize dimebon latrepirdine 58 Praxity global 58 Oncolys 58 ERYtech 58 LUCASSIN 58 JSB Partners 58 Nasdaq PGNX today 58 Eyetech Pharmaceuticals 58 Novartis Sandoz 58 oral Janus kinase 58 Receives Tentative FDA 58 Extend Collaboration 58 Fovea Pharmaceuticals SA 58 RapMAT R 58 Genpharm 58 FOLOTYN ® 58 http:/www.sunesis.com 58 PhotoCure 58 Napo Pharmaceuticals 58 Locteron combines 58 novel orally inhaled 58 Tostrex 58 commercialize CorMedix drug 58 BiDil XR 58 Sanvar R 58 oxandrolone USP 58 Amyris oversees 58 NASDAQ ALNY 58 Catalyst Biosciences 58 Nasdaq ALNY 58 NASDAQ RNAI 58 Angelini Labopharm 58 Lexapro escitalopram 58 Zevtera TM 58 Receives Complete Response 58 Neurimmune 58 Teikoku Seiyaku 58 Ortho Cept 58 R sorafenib tablets 58 Grünenthal GmbH 58 sanofi aventis GlaxoSmithKline 58 Jubilant Biosys 58 Enters Into Exclusive 58 fusion enhancers 58 Sign License Agreement 58 Nanobody R 58 GlaxoSmithKline Biologicals SA 58 Elan Pharma 58 Recon Mountaineer LLC 58 TM pralatrexate injection 58 Inc. www.prometic.com 58 Fovea Pharmaceuticals subsidiary 58 phenylketonuria PKU developed 58 Fludara ® 58 GeneraMedix 58 Nereus Pharmaceuticals 58 FivePrime Therapeutics 58 please visit http:/www.vandapharma.com 58 DsiRNA pharmaceuticals 58 rusalatide acetate 58 Amide 58 Empatic ™ 58 molecular imaging radiopharmaceutical 58 Amend Merger Agreement 58 NASDAQ OMX NORDIC ACTI 58 Levaquin levofloxacin 58 BioProgress plc 58 TSX PLB 58 STRIANT ® 58 sitagliptin metformin 58 Aganocide 58 Alnara Pharmaceuticals 58 ALTANA Pharma AG 58 Pliaglis 58 Regulus Therapeutics 58 Dexilant 58 FDA Accepts 58 Pharmaceuticals Initiates 58 Ascentage Pharma 58 Nasdaq IDIX biopharmaceutical 58 Rottapharm Madaus 58 dihydrochloride Tablets 58 CARBATROL 58 Task Force ACTF 58 TSX VENTURE IGX OTCBB 58 BUPHENYL R 58 Cephalon GlaxoSmithKline Organon 58 personalized cellular immunotherapy 58 Falk Pharma 58 CONBRIZA 58 Subsidiary Enters 58 Ethypharm SA 58 highly purified pasteurized 58 Announce Licensing Agreement 58 Veregen R 58 Vaccinex 58 Milestone Payment From 58 proprietary intravenous formulation 58 owned subsidiary CIMYM 58 Pruvel TM 58 Psivida 58 lead molecular radiotherapeutic 58 Ridaforolimus 58 Peginterferon alfa 2b 58 Colaris Colaris AP 57 Inc. www.coopersurgical.com develops 57 Celladon Corporation 57 Medicexchange PLC 57 Oxford Genome Sciences 57 Reveals Positive 57 Ono Pharmaceutical 57 Wellstat 57 Drug Candidate 57 Nasdaq XTLB 57 ThromboGenics NV 57 Tech DVAX 57 RECOTHROM R 57 Phase III multicenter 57 Announcement acc 57 Announce Shareholder Approval 57 Emisphere Technologies 57 Exelixis logo 57 Schering Pharma 57 Eligard ® 57 AION Diagnostics 57 ® adefovir dipivoxil 57 Replagal TM 57 Oracea ® 57 OTCBB URGP specialty 57 Telik logo TELINTRA 57 Commences Phase 57 GlaxoSmithKline Bristol Myers 57 HYVISC R 57 Akzo Nobel Organon 57 volociximab 57 liver resection surgeries 57 evaluating satraplatin 57 Andrx Corporation 57 Genetronics 57 staphylococcal vaccines 57 Rohto Pharmaceutical 57 Application MAA 57 Kaketsuken 57 ILEX Oncology 57 Furiex Pharmaceuticals 57 Locked Nucleic Acid 57 Hsp# Inhibitor 57 Nasdaq LXRX biopharmaceutical 57 Nabi HB R 57 Shire BioChem Inc. 57 NYSE PFE Exelon Rivastigmine 57 Dealmaking Profile 57 BioInvent International 57 Valtropin 57 DepoCyt ® Abelcet ® 57 Zenpep 57 IV APAP 57 KRYSTEXXA TM pegloticase 57 Sigma Tau SpA 57 Nasdaq EPCT 57 Albugon 57 Nasdaq PGNX 57 Conforma Therapeutics 57 include ClindaReach TM 57 Picchio Pharma Inc. 57 Enzon Pharmaceuticals Inc 57 BioNumerik 57 therapeutically inactive prodrug 57 Inc. Nasdaq NEOL 57 CPL Biologicals 57 Phusion Laboratories 57 induced angioedema 57 Mersana Therapeutics Inc. 57 therefore therapeutically equivalent 57 Becton Dickinson BD 57 DIFICID ™ 57 4SC AG ISIN DE# 57 Cypress Bioscience Inc 57 Copegus ® 57 Announce Initiation 57 Inks Distribution 57 adenosine injection 57 Epiphany Biosciences 57 targeted anticancer biopharmaceuticals 57 Nasdaq VNDA 57 RELOVAIR ™ 57 trastuzumab Herceptin R 57 R lenalidomide 57 Rega Institute 57 research anddevelopment 57 2A receptor agonist 57 Ophthotech 57 delta opioid receptor 57 Alnylam dependence 57 microRNA antagonists 57 rasagiline tablets 57 Adenosine Therapeutics 57 Mg Usa 57 codevelopment 57 XIAPEX 57 VISICOL R 57 ATRA IV 57 Synerx 57 Argatroban 57 IMiDs ® compound 57 NYSE Amex PTN 57 Misonix Announces 57 commercialize Aganocide compounds 57 Biolipox 57 Begins Shipment 57 small molecule glucokinase 57 erlotinib Tarceva R 57 OTC ZEGERID 57 Valeant Pharma 57 CHDI Foundation 57 Idun Pharmaceuticals 57 NeutroPhase TM 57 markets COLAZAL 57 OctoPlus licensed 57 UCB www.ucb group.com 57 Inc FRX 57 UCB Pharma 57 Mg Uk 57 Mochida Pharmaceutical Co. 57 Esteve SA 57 Perforomist TM formoterol fumarate 57 memantine HCl 57 Serostim ® 57 Xoma Ltd 57 Submits Supplemental 57 Uvidem 57 recombinant thrombin 57 LFB Biotechnologies 57 FDA APPROVES 57 SIMCOR ® 57 JOULFERON 57 Idenix Novartis 57 histamine dihydrochloride 57 Shai Novik President 57 NIBR 57 Aegera Therapeutics 57 Botaneco Specialty Ingredients 57 Reinach Switzerland 57 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 57 Janssen Alzheimer Immunotherapy 57 GeneraMedix Inc. 57 Cardium Therapeutics TM 57 BTG plc 57 SYN X 57 Onalta TM 57 XL# anticancer compounds 57 DURIN TM 57 Retavase 57 Juvantia 57 Quark Pharmaceuticals 57 based Cegedim SA 57 Restructures Operations 57 InterfeRx TM 57 pentadentate logo R 57 Demonstrates Positive 57 Esmya 57 rheumatoid arthritis Roche PEGASYS 57 Agios Pharmaceuticals 57 Marnac 57 Esprit Pharma 57 Myriad logo BRACAnalysis 57 PsychoGenics 57 Horizant ™ 57 GSK '# 57 Pirespa 57 Amlodipine Besylate 57 Nasdaq IDIX 57 Milestone Payments 57 Orient Europharma 57 Rinat Neuroscience 57 Somatuline R Depot 57 Inc. NASDAQ DRTE 57 palonosetron hydrochloride Injection Dacogen 57 drug pipeline TAFA# 57 rxRNA 57 Vitaflo Scandinavia AB 57 Alvesco ® 57 Teijin Pharma Limited 57 GATTEX TM 57 novel therapeutic antibodies 57 allosteric modulator PAM 57 Pruvel ™ 57 GVAX ® 57 Adamis Laboratories 57 Emezine R 57 Aeolus Pharmaceuticals Announces 57 Valortim TM 57 Kyowa Hakko Kirin 57 Galapagos NV Euronext GLPG 57 Entocort 57 Generx TM 57 Ucyclyd Pharma Inc. 57 OncoMed Pharmaceuticals 57 AcryMed technologies 57 sublicensee 57 OTC RHHBY 57 Nostrum Pharmaceuticals 57 Prodarsan R 57 Alfa Wassermann 57 Aceon 57 Myocet 57 Helsinn Healthcare SA 57 Salmedix 57 sigma tau Group 57 Azmacort R 57 ProSkelia 57 Galderma Pharma 57 mitoxantrone concentrate 57 Ropinirole 57 Brussels THR 57 RhuDex ® 57 developing adecatumumab 57 FACTIVE ® 57 AAG geldanamycin analog 57 selective estrogen receptor modulator 57 antibacterial therapeutics 57 Celera Diagnostics joint venture 57 Omacor ® 57 Kosan motilin agonist 57 Rhein Biotech GmbH 57 CD# CEA 57 Inc Therapeutic Competitors 57 Xytis 57 ZALBIN 57 Cariprazine 57 Nerviano Medical Sciences 57 provides adenoviral reagents 57 NerPharMa 57 Zenyaku Kogyo 57 Samjin 57 Biomarker Study 57 Friedreich Ataxia FRDA 57 BUPHENYL 57 ASX PGL 57 technology visit http:/www.genmab.com 57 apricitabine ATC 57 Anti Infective 57 Establishes Strategic 57 t2cure GmbH 57 balsalazide tablet 57 Terminates Merger Agreement 57 Ergomed 57 Aloxi ® 57 anti inflammatory NSAID 57 subsidiaries Medicsight PLC 57 commercialize OncoGenex lead 57 Viatris 57 Enters Into Strategic 57 Peyronie disease Frozen Shoulder 57 Trastuzumab DM1 57 Onco TCS 57 Newron Pharmaceuticals 57 FORMA Therapeutics 57 DNA methyltransferase inhibitors 57 Syntonix 57 Japanese Encephalitis Vaccine 57 Mimpara R 57 Rhone Poulenc Rorer 57 partner Mallinckrodt Imaging 57 Nasdaq AVNC 57 NasdaqGM SPPI 57 sapropterin dihydrochloride 57 vitro pharmacology 56 Teijin Pharma 56 Aloprim TM allopurinol sodium 56 Phase 2b Clinical Trial 56 Predictive medicine 56 Inc. Tianlong 56 Budesonide foam crofelemer 56 Zalypsis 56 Otsuka Pharmaceuticals 56 Amgen Bayer Schering 56 Biovail Laboratories International 56 INDICATED HIGHER 56 PharmaSwiss 56 INTEGRILIN R eptifibatide Injection 56 delivers fluocinolone acetonide FA 56 developing ostarine selective 56 subsidiaries visit http:/www.apricusbio.com 56 Arpida SWX ARPN 56 Solazed TM 56 equine osteoarthritis marketed 56 Martinsried Germany 56 Through Glycoscience R 56 Debmar Mercury LLC 56 Actelion Pharmaceuticals Ltd 56 WILEX AG 56 NASDAQ PPDI 56 TFChem 56 Sirion Therapeutics 56 CyDex Pharmaceuticals Inc. 56 Retains CCG Investor Relations 56 PREOS R 56 superparamagnetic iron oxide nanoparticles 56 Tanabe Seiyaku 56 Circ Pharma 56 Vitamin D analogue 56 Silodosin 56 CorMedix dependence 56 selective androgen receptor modulators 56 PRAVACHOL R 56 Jean François Labbé 56 BioPartners 56 Merz Pharmaceuticals GmbH 56 Manja Bouman CEO 56 Hextend R 56 Nasdaq ABII 56 Capsulution 56 Investigational Oral 56 Urocidin TM 56 Merck Serono 56 CEFF financings subject 56 XL# XL# 56 NASDAQ IDEV 56 StromaCel Inc. 56 Present Preclinical Data 56 JAK inhibitor 56 Announces Licensing Agreement 56 Radebeul Germany 56 CORTOSS R 56 markets Testim ® 56 SANKYO 56 Rheumatoid Arthritis Drug 56 Altana Pharma 56 GVK Bio 56 ABILIFY ® 56 German drugmaker Boehringer 56 Explores Strategic Alternatives 56 Sensipar R 56 CORLUX CORT # 56 Zentaris GmbH 56 DepoBupivacaine TM 56 var arrContent = 56 Proellex TM 56 P#X# antagonist 56 Bayer Schering 56 Zegerid OTC 56 ZEFTERA TM Zevtera TM 56 Clinigene 56 CyDex Pharmaceuticals 56 affiliate Evogene Ltd. TASE 56 Loramyc 56 Vytorin combines 56 Adenuric ® 56 FoldRx Pharmaceuticals Inc. 56 Nordic Bioscience 56 apply Enhanze technology 56 innovator Daiichi Sankyo 56 Dementia Related Psychosis 56 collagenase clostridium histolyticum 56 NASDAQ SCMP 56 Elvitegravir 56 Nasdaq RIGL 56 Neuromed Pharmaceuticals Ltd. 56 Pierre Fabre Medicament 56 successfully commercialize Silenor 56 MERREM 56 Fosphenytoin 56 inVentiv Clinical 56 BioSyent Pharma 56 ALTROPANE R 56 humanized therapeutic 56 NASDAQ LGND 56 NS5b 56 KAI Pharmaceuticals Inc. 56 aerosolized AAT 56 OTCBB ARGA specialty 56 Posidur 56 Amex KAL 56 3M Completes Acquisition 56 Teva Provides Update 56 Newron Pharmaceuticals SpA 56 Mundipharma 56 Submits Application 56 TRX1 56 DOVONEX 56 Antisense Pharma GmbH 56 PDE4 inhibitor 56 Certara unites Tripos 56 Canadian subsidiary CIMYM 56 Levocetirizine 56 AMEX RGN 56 ONYX PHARMACEUTICALS 56 promotes MERREM ® 56 Nippon Organon 56 Reports Inducement Grants 56 gepirone ER 56 Sanofi Pasteur GlaxoSmithKline 56 factor TNF receptor 56 Completes Merger With 56 chimeric monoclonal antibody 56 Nasdaq IMGN 56 Novel Oral 56 Joins Medidata Solutions 56 Euronext Brussels ABLX 56 PAION AG ISIN 56 enoxaparin sodium injection 56 VIVITROL ® 56 DAIICHI SANKYO 56 nasal calcitonin product 56 Dexo 56 Drug Fails 56 Rhucin ® recombinant 56 candidate AQ4N 56 THALOMID R 56 Finalizes Joint Venture 56 Investigational Treatment 56 Sylvie Gregoire President 56 adrenergic regulation 56 Receives Positive Opinion 56 lexidronam injection 56 Daiichi Suntory Pharma 56 Febuxostat 56 Benicar ® 56 apaziquone 56 Seikagaku 56 leading lipid nanoparticle 56 Oxford BioTherapeutics 56 lixivaptan 56 IV Busulfex 56 candidate custirsen 56 Envirokare Tech Inc. 56 Glenmark Pharmaceuticals Limited 56 Ethypharm 56 Marketing Authorisation Application MAA 56 Ikaria Holdings Inc. 56 Argenta Discovery 56 ZFP Therapeutics 56 Announce Early Termination 56 Astex Therapeutics Limited 56 sanofi